NIBRT to join SSPC, strengthening collaborative ties to drive innovation in the biopharma sector

October 25, 2024 09:31 PM AEDT | By EIN Presswire
 NIBRT to join SSPC, strengthening collaborative ties to drive innovation in the biopharma sector
Image source: EIN Presswire

LIMERICK, IRELAND, October 25, 2024 /EINPresswire.com/ -- SSPC, the Research Ireland Centre for Pharmaceuticals, hosted at the University of Limerick, has announced that it is to expand its research capabilities with the addition of The National Institute for Bioprocessing Research and Training (NIBRT) as a partner. This collaboration builds on a strong track record of successful joint initiatives between SSPC and NIBRT, aiming to further advance the development of innovative technologies that address critical industry challenges.

SSPC has a strong commitment to collaborate with world-leading institutes to foster a culture of knowledge-sharing and accelerated progress in pharmaceutical and biopharmaceutical research. With over 80 investigators, SSPC has assembled scientists and engineers to work collaboratively to provide innovations that have the potential to benefit humanity for years to come.

With this important step, SSPC and NIBRT are building on a long history of partnership to address ambitious research challenges. Notable examples of recent collaborations, which demonstrate the diversity of links between the two organisations and showcase the range of expertise being shared, include:

• The Research Ireland-funded Advanced Biopharmaceutical Technologies Spokes Project, in partnership with seven major biopharma companies and involving NIBRT Principal Investigators (PIs) Prof. Niall Barron and Assoc. Prof. Jonathan Bones. The topic, extractables and leachables, is of high relevance to the pharmaceutical industry today due to their potential impact on drug safety and efficacy.

• Assoc. Prof. Steven Ferguson is both a NIBRT and SSPC Co-Principal Investigator, where his manufacturing theme is strongly aligned to industry with a focus on enabling a disruptive change in the manufacture of drug substances and drug products.

• NIBRT PIs Prof. Elizabeth Topp and Prof. Anne Moore are also funded Investigators in SSPC. Leveraging Prof Topp’s expertise and leadership position within the global consortium LyoHub, NIBRT and SSPC have been working together on a training collaboration in formulation and lyophilisation processes.

Commenting on the announcement, Prof. Damien Thompson, SSPC Scientific Director, said: “This collaboration represents a key step forward to innovate and deliver life-changing therapies in the (bio)pharma space in Ireland. By combining our expertise and resources, we are poised to advance science and talent. Ensuring that Ireland remains at the forefront of global pharmaceutical research and development is essential, and we are delighted to see such a high calibre partner come on board.”

“We are delighted to deepen our partnership with SSPC, a leading research centre that shares our commitment to advancing the pharmaceutical and biopharmaceutical sectors by pulling together excellent researchers and research groups from across Ireland’s research institutes towards a common objective”, commented Dr Darrin Morrissey, NIBRT CEO. “This alliance allows us to leverage each other's strengths, accelerating innovation and providing even greater support to industry as we work together to address some of the sector’s most complex challenges.”

The partnership marks an exciting step forward. Building on an already-established relationship, NIBRT’s membership of SSPC will significantly enhance both organisations' ability to achieve their strategic goals. This alliance will unlock new opportunities by combining NIBRT’s deep expertise in biopharmaceutical manufacturing research, state-of-the-art research infrastructure and equipment, with SSPC’s cutting-edge pharmaceutical research, offering access to extensive specialist resources, infrastructure, and talent.

About NIBRT
The National Institute for Bioprocessing Research and Training (NIBRT) is a centre of excellence for training and research in biopharmaceutical manufacturing. NIBRT is located in a world class facility in Dublin, Ireland. This facility is purpose built to replicate a modern bioprocessing plant with state-of-the-art equipment and enables NIBRT to offer the highest quality training and research solutions. NIBRT’s mission is to support the growth and development of all aspects of the biopharmaceutical manufacturing industry. For more information, please visit www.nibrt.ie.
Media Contact: Emer Norton, NIBRT Marketing and Communications Manager, [email protected]. Phone: +353 1 215 8100

About SSPC
SSPC, the Research Ireland Centre for Pharmaceuticals, funded by Taighde Éireann – Research Ireland, formerly Science Foundation Ireland, is a hub of Irish research expertise developing innovative technologies to address key challenges facing the (bio)pharmaceutical industry. SSPC delivers industry-relevant technical solutions, which result in job growth and retention within this sector in Ireland and grow the skills base of qualified scientists and engineers. For more information, please visit www.sspc.ie. You can follow SSPC on X (@SSPCentre) and LinkedIn.

Louise O'Neill
SSPC, the Research Ireland Centre for Pharmaceuticals
+353 87 930 8585
email us here
Visit us on social media:
LinkedIn
Instagram
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.